- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
According to our latest study, the global Human Rabies Vaccine market size was valued at USD 1086.6 million in 2022 and is forecast to a readjusted size of USD 1441 million by 2029 with a CAGR of 4.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.
Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.
Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 70% of the share.
This report is a detailed and comprehensive analysis for global Human Rabies Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Rabies Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Rabies Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Rabies Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Rabies Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Rabies Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Rabies Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio and KANGH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Human Rabies Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others
Market segment by Application
Pre-Exposure Vaccine
Post-Exposure Vaccine
Major players covered
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Rabies Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Rabies Vaccine, with price, sales, revenue and global market share of Human Rabies Vaccine from 2018 to 2023.
Chapter 3, the Human Rabies Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rabies Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Rabies Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Rabies Vaccine.
Chapter 14 and 15, to describe Human Rabies Vaccine sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Human Rabies Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Rabies Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Vero Cell
1.3.3 BHK
1.3.4 Chick Embryo Cell
1.3.5 Human Diploid Cells
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Rabies Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pre-Exposure Vaccine
1.4.3 Post-Exposure Vaccine
1.5 Global Human Rabies Vaccine Market Size & Forecast
1.5.1 Global Human Rabies Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Rabies Vaccine Sales Quantity (2018-2029)
1.5.3 Global Human Rabies Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business
2.1.3 Bharat Biotech Human Rabies Vaccine Product and Services
2.1.4 Bharat Biotech Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bharat Biotech Recent Developments/Updates
2.2 Bavarian Nordic
2.2.1 Bavarian Nordic Details
2.2.2 Bavarian Nordic Major Business
2.2.3 Bavarian Nordic Human Rabies Vaccine Product and Services
2.2.4 Bavarian Nordic Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bavarian Nordic Recent Developments/Updates
2.3 Sanofi-Pasteur
2.3.1 Sanofi-Pasteur Details
2.3.2 Sanofi-Pasteur Major Business
2.3.3 Sanofi-Pasteur Human Rabies Vaccine Product and Services
2.3.4 Sanofi-Pasteur Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi-Pasteur Recent Developments/Updates
2.4 Chengda Bio
2.4.1 Chengda Bio Details
2.4.2 Chengda Bio Major Business
2.4.3 Chengda Bio Human Rabies Vaccine Product and Services
2.4.4 Chengda Bio Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Chengda Bio Recent Developments/Updates
2.5 KANGH
2.5.1 KANGH Details
2.5.2 KANGH Major Business
2.5.3 KANGH Human Rabies Vaccine Product and Services
2.5.4 KANGH Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 KANGH Recent Developments/Updates
2.6 Prcmise
2.6.1 Prcmise Details
2.6.2 Prcmise Major Business
2.6.3 Prcmise Human Rabies Vaccine Product and Services
2.6.4 Prcmise Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Prcmise Recent Developments/Updates
2.7 Henan Grand Biopharma
2.7.1 Henan Grand Biopharma Details
2.7.2 Henan Grand Biopharma Major Business
2.7.3 Henan Grand Biopharma Human Rabies Vaccine Product and Services
2.7.4 Henan Grand Biopharma Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Henan Grand Biopharma Recent Developments/Updates
2.8 Zhuoyi Biological
2.8.1 Zhuoyi Biological Details
2.8.2 Zhuoyi Biological Major Business
2.8.3 Zhuoyi Biological Human Rabies Vaccine Product and Services
2.8.4 Zhuoyi Biological Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Zhuoyi Biological Recent Developments/Updates
2.9 ZhongKe Biopharm
2.9.1 ZhongKe Biopharm Details
2.9.2 ZhongKe Biopharm Major Business
2.9.3 ZhongKe Biopharm Human Rabies Vaccine Product and Services
2.9.4 ZhongKe Biopharm Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 ZhongKe Biopharm Recent Developments/Updates
2.10 Ningbo Rongan Biological
2.10.1 Ningbo Rongan Biological Details
2.10.2 Ningbo Rongan Biological Major Business
2.10.3 Ningbo Rongan Biological Human Rabies Vaccine Product and Services
2.10.4 Ningbo Rongan Biological Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Ningbo Rongan Biological Recent Developments/Updates
2.11 Indian Immunologicals
2.11.1 Indian Immunologicals Details
2.11.2 Indian Immunologicals Major Business
2.11.3 Indian Immunologicals Human Rabies Vaccine Product and Services
2.11.4 Indian Immunologicals Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Indian Immunologicals Recent Developments/Updates
3 Competitive Environment: Human Rabies Vaccine by Manufacturer
3.1 Global Human Rabies Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Rabies Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Human Rabies Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Rabies Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Rabies Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Human Rabies Vaccine Manufacturer Market Share in 2022
3.5 Human Rabies Vaccine Market: Overall Company Footprint Analysis
3.5.1 Human Rabies Vaccine Market: Region Footprint
3.5.2 Human Rabies Vaccine Market: Company Product Type Footprint
3.5.3 Human Rabies Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Human Rabies Vaccine Market Size by Region
4.1.1 Global Human Rabies Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Human Rabies Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Human Rabies Vaccine Average Price by Region (2018-2029)
4.2 North America Human Rabies Vaccine Consumption Value (2018-2029)
4.3 Europe Human Rabies Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Human Rabies Vaccine Consumption Value (2018-2029)
4.5 South America Human Rabies Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Human Rabies Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Human Rabies Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Human Rabies Vaccine Consumption Value by Type (2018-2029)
5.3 Global Human Rabies Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Human Rabies Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Human Rabies Vaccine Consumption Value by Application (2018-2029)
6.3 Global Human Rabies Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Human Rabies Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Human Rabies Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Human Rabies Vaccine Market Size by Country
7.3.1 North America Human Rabies Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Human Rabies Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Human Rabies Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Human Rabies Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Human Rabies Vaccine Market Size by Country
8.3.1 Europe Human Rabies Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Rabies Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Human Rabies Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Rabies Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Rabies Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Rabies Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Rabies Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Human Rabies Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Human Rabies Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Human Rabies Vaccine Market Size by Country
10.3.1 South America Human Rabies Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Human Rabies Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Human Rabies Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Rabies Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Rabies Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Rabies Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Rabies Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Human Rabies Vaccine Market Drivers
12.2 Human Rabies Vaccine Market Restraints
12.3 Human Rabies Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Human Rabies Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Rabies Vaccine
13.3 Human Rabies Vaccine Production Process
13.4 Human Rabies Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Rabies Vaccine Typical Distributors
14.3 Human Rabies Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Human Rabies Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Rabies Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Bharat Biotech Major Business
Table 5. Bharat Biotech Human Rabies Vaccine Product and Services
Table 6. Bharat Biotech Human Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bharat Biotech Recent Developments/Updates
Table 8. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 9. Bavarian Nordic Major Business
Table 10. Bavarian Nordic Human Rabies Vaccine Product and Services
Table 11. Bavarian Nordic Human Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bavarian Nordic Recent Developments/Updates
Table 13. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi-Pasteur Major Business
Table 15. Sanofi-Pasteur Human Rabies Vaccine Product and Services
Table 16. Sanofi-Pasteur Human Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi-Pasteur Recent Developments/Updates
Table 18. Chengda Bio Basic Information, Manufacturing Base and Competitors
Table 19. Chengda Bio Major Business
Table 20. Chengda Bio Human Rabies Vaccine Product and Services
Table 21. Chengda Bio Human Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Chengda Bio Recent Developments/Updates
Table 23. KANGH Basic Information, Manufacturing Base and Competitors
Table 24. KANGH Major Business
Table 25. KANGH Human Rabies Vaccine Product and Services
Table 26. KANGH Human Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. KANGH Recent Developments/Updates
Table 28. Prcmise Basic Information, Manufacturing Base and Competitors
Table 29. Prcmise Major Business
Table 30. Prcmise Human Rabies Vaccine Product and Services
Table 31. Prcmise Human Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Prcmise Recent Developments/Updates
Table 33. Henan Grand Biopharma Basic Information, Manufacturing Base and Competitors
Table 34. Henan Grand Biopharma Major Business
Table 35. Henan Grand Biopharma Human Rabies Vaccine Product and Services
Table 36. Henan Grand Biopharma Human Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Henan Grand Biopharma Recent Developments/Updates
Table 38. Zhuoyi Biological Basic Information, Manufacturing Base and Competitors
Table 39. Zhuoyi Biological Major Business
Table 40. Zhuoyi Biological Human Rabies Vaccine Product and Services
Table 41. Zhuoyi Biological Human Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Zhuoyi Biological Recent Developments/Updates
Table 43. ZhongKe Biopharm Basic Information, Manufacturing Base and Competitors
Table 44. ZhongKe Biopharm Major Business
Table 45. ZhongKe Biopharm Human Rabies Vaccine Product and Services
Table 46. ZhongKe Biopharm Human Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. ZhongKe Biopharm Recent Developments/Updates
Table 48. Ningbo Rongan Biological Basic Information, Manufacturing Base and Competitors
Table 49. Ningbo Rongan Biological Major Business
Table 50. Ningbo Rongan Biological Human Rabies Vaccine Product and Services
Table 51. Ningbo Rongan Biological Human Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Ningbo Rongan Biological Recent Developments/Updates
Table 53. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 54. Indian Immunologicals Major Business
Table 55. Indian Immunologicals Human Rabies Vaccine Product and Services
Table 56. Indian Immunologicals Human Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Indian Immunologicals Recent Developments/Updates
Table 58. Global Human Rabies Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Human Rabies Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Human Rabies Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Human Rabies Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Human Rabies Vaccine Production Site of Key Manufacturer
Table 63. Human Rabies Vaccine Market: Company Product Type Footprint
Table 64. Human Rabies Vaccine Market: Company Product Application Footprint
Table 65. Human Rabies Vaccine New Market Entrants and Barriers to Market Entry
Table 66. Human Rabies Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Human Rabies Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Human Rabies Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Human Rabies Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Human Rabies Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Human Rabies Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Human Rabies Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Human Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Human Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Human Rabies Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Human Rabies Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Human Rabies Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Human Rabies Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Human Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Human Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Human Rabies Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Human Rabies Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Human Rabies Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Human Rabies Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Human Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Human Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Human Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Human Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Human Rabies Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Human Rabies Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Human Rabies Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Human Rabies Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Human Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Human Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Human Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Human Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Human Rabies Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Human Rabies Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Human Rabies Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Human Rabies Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Human Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Human Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Human Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Human Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Human Rabies Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Human Rabies Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Human Rabies Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Human Rabies Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Human Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Human Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Human Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Human Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Human Rabies Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Human Rabies Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Human Rabies Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Human Rabies Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Human Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Human Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Human Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Human Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Human Rabies Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Human Rabies Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Human Rabies Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Human Rabies Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Human Rabies Vaccine Raw Material
Table 126. Key Manufacturers of Human Rabies Vaccine Raw Materials
Table 127. Human Rabies Vaccine Typical Distributors
Table 128. Human Rabies Vaccine Typical Customers
List of Figures
Figure 1. Human Rabies Vaccine Picture
Figure 2. Global Human Rabies Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Rabies Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Vero Cell Examples
Figure 5. BHK Examples
Figure 6. Chick Embryo Cell Examples
Figure 7. Human Diploid Cells Examples
Figure 8. Others Examples
Figure 9. Global Human Rabies Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Human Rabies Vaccine Consumption Value Market Share by Application in 2022
Figure 11. Pre-Exposure Vaccine Examples
Figure 12. Post-Exposure Vaccine Examples
Figure 13. Global Human Rabies Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Human Rabies Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Human Rabies Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Human Rabies Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Human Rabies Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Human Rabies Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Human Rabies Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Human Rabies Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Human Rabies Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Human Rabies Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Human Rabies Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Human Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Human Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Human Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Human Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Human Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Human Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Human Rabies Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Human Rabies Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Human Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Human Rabies Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Human Rabies Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Human Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Human Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Human Rabies Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Human Rabies Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Human Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Human Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Human Rabies Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Human Rabies Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Human Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Human Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Human Rabies Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Human Rabies Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 55. China Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Human Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Human Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Human Rabies Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Human Rabies Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Human Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Human Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Human Rabies Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Human Rabies Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Human Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Human Rabies Vaccine Market Drivers
Figure 76. Human Rabies Vaccine Market Restraints
Figure 77. Human Rabies Vaccine Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Human Rabies Vaccine in 2022
Figure 80. Manufacturing Process Analysis of Human Rabies Vaccine
Figure 81. Human Rabies Vaccine Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
